BIOTON S.A. (WSE:BIO)
4.020
-0.030 (-0.74%)
Jan 21, 2026, 4:43 PM CET
BIOTON Market Cap
BIOTON has a market cap or net worth of 347.75 million as of January 21, 2026. Its market cap has increased by 40.38% in one year.
Market Cap
347.75M
Enterprise Value
389.47M
Revenue
295.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.02
Market Cap Chart
Since July 1, 2005, BIOTON's market cap has decreased from 1.09B to 347.75M, a decrease of -68.19%. That is a compound annual growth rate of -5.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 347.75M | 4.92% |
| Dec 30, 2025 | 331.44M | 33.80% |
| Dec 30, 2024 | 247.72M | -19.19% |
| Dec 29, 2023 | 306.54M | 5.93% |
| Dec 30, 2022 | 289.36M | -19.47% |
| Dec 30, 2021 | 359.34M | -2.21% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 6.62B |
| NEUCA | 3.66B |
| Synektik Spólka Akcyjna | 2.56B |
| Voxel | 1.49B |
| Celon Pharma | 1.13B |
| Selvita | 860.87M |
| Ryvu Therapeutics | 624.24M |
| Centrum Medyczne ENEL-MED | 528.84M |